Unibest
← Back to patent-cliff list

CAS 461699-13-8

tert-butyl 3-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate

Codes: Rilza-004

Application context (from source-drug indications)

Immune thrombocytopenic purpuraRilzabrutinib免疫球蛋白G4相关疾病RilzabrutinibAutoimmune haemolytic anaemiaRilzabrutinibSickle cell diseaseRilzabrutinib格雷夫斯病RilzabrutinibAsthmaRilzabrutinib

Source drugs (routes using this intermediate)

DrugTierExpiry
RilzabrutinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works(2-fluoro-4-phenoxyphenyl)boronic acid
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like SiteBenzyl 4-(oxetan-3-yl)piperazine-1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.